Arcellx (ACLX) Net Cash Flow (2021 - 2025)
Arcellx (ACLX) recorded quarterly Net Cash Flow of $1.3 million in Q4 2025, down 92.55% quarter-over-quarter from $16.9 million in Q3 2025, and up 102.24% on a YoY basis from $621545.0 in Q4 2024.
Arcellx (ACLX) Net Cash Flow (2021 - 2025) Analysis & Trends
Arcellx's Net Cash Flow history runs 5 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- In Q4 2025, Net Cash Flow rose 102.24% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at -$25.4 million (up 91.25% YoY), while the FY2025 annual figure was -$25.4 million, up 91.25% from the prior year.
- Net Cash Flow was $1.3 million for Q4 2025 at Arcellx, down from $16.9 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $267.9 million in Q4 2023 to a low of -$241.7 million in Q1 2024.
- Historically, Net Cash Flow has averaged $1.8 million across 5 years, with a median of $4.3 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Net Cash Flow jumped 3511.87% in 2023, then plunged 289.58% in 2024.
- A 5-year view of Net Cash Flow shows it stood at -$39.2 million in 2021, then soared by 118.92% to $7.4 million in 2022, then surged by 3511.87% to $267.9 million in 2023, then plunged by 120.97% to -$56.2 million in 2024, then surged by 102.24% to $1.3 million in 2025.
- The last three Net Cash Flow figures came in at $1.3 million (Q4 2025), $16.9 million (Q3 2025), and -$18.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 1.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 16.87 Mn |
| Sep 30, 2025 | 16.87 Mn |
| Jun 30, 2025 | -18.73 Mn |
| Jun 30, 2025 | -18.73 Mn |
| Mar 31, 2025 | -24.82 Mn |
| Mar 31, 2025 | -24.82 Mn |
| Dec 31, 2024 | -56.17 Mn |
| Dec 31, 2024 | -56.17 Mn |
| Sep 30, 2024 | 61.82 Mn |
| Sep 30, 2024 | 61.82 Mn |
| Jun 30, 2024 | -54.55 Mn |
| Jun 30, 2024 | -54.55 Mn |
| Mar 31, 2024 | -241.70 Mn |
| Mar 31, 2024 | -241.70 Mn |
| Dec 31, 2023 | 267.86 Mn |
| Dec 31, 2023 | 267.86 Mn |
| Sep 30, 2023 | -175.12 Mn |
| Sep 30, 2023 | -175.12 Mn |